↓ Skip to main content

Rifamycin SV MMX®: A Review in the Treatment of Traveller’s Diarrhoea

Overview of attention for article published in Clinical Drug Investigation, June 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (74th percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

news
1 news outlet

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
18 Mendeley
Title
Rifamycin SV MMX®: A Review in the Treatment of Traveller’s Diarrhoea
Published in
Clinical Drug Investigation, June 2019
DOI 10.1007/s40261-019-00808-2
Pubmed ID
Authors

Sheridan M. Hoy

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 18 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 3 17%
Student > Bachelor 3 17%
Other 1 6%
Student > Doctoral Student 1 6%
Student > Ph. D. Student 1 6%
Other 1 6%
Unknown 8 44%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 3 17%
Pharmacology, Toxicology and Pharmaceutical Science 2 11%
Medicine and Dentistry 2 11%
Nursing and Health Professions 1 6%
Immunology and Microbiology 1 6%
Other 1 6%
Unknown 8 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 June 2019.
All research outputs
#4,255,084
of 23,150,406 outputs
Outputs from Clinical Drug Investigation
#123
of 982 outputs
Outputs of similar age
#86,349
of 353,521 outputs
Outputs of similar age from Clinical Drug Investigation
#2
of 14 outputs
Altmetric has tracked 23,150,406 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 982 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.8. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 353,521 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.